Abstract:Background: Multiple studies have demonstrated associations between the early-life gut microbiome and incidence of inflammatory and autoimmune disease in childhood. Although microbial colonization is necessary for proper immune education, it is not well understood at a mechanistic level how specific communities of bacteria promote immune maturation or drive immune dysfunction in infancy. Objectives: In this study, we aimed to assess whether infant microbial communities with different overall structures differentially influence immune and gastrointestinal development in healthy mice. Methods: Germ-free mice were inoculated with fecal slurries from Bifidobacterium longum subspecies infantis positive (BIP) or B. longum subspecies infantis negative (BIN) breastfed infants; half of the mice in each group were also supplemented with a pool of human milk oligosaccharides (HMOs) for 14 d. Cecal microbiome composition and metabolite production, systemic and mucosal immune outcomes, and intestinal morphology were assessed at the end of the study. Results: The results showed that inoculation with a BIP microbiome results in a remarkably distinct microbial community characterized by higher relative abundances of cecal Clostridium senu stricto, Ruminococcus gnavus, Cellulosilyticum sp., and Erysipelatoclostridium sp. The BIP microbiome produced 2-fold higher concentrations of cecal butyrate, promoted branched short-chain fatty acid (SCFA) production, and further modulated serotonin, kynurenine, and indole metabolism relative to BIN mice. Further, the BIP microbiome increased the proportions of innate and adaptive immune cells in spleen, while HMO supplementation increased proliferation of mesenteric lymph node cells to phorbol myristate acetate and lipopolysaccharide and increased serum IgA and IgG concentrations. Conclusions: Different microbiome compositions and HMO supplementation can modulate SCFA and tryptophan metabolism and innate and adaptive immunity in young, healthy mice, with potentially important implications for early childhood health.

The ontogeny of immune tolerance: a model of early-life secretory IgA - gut microbiome interactions

Priming for Life: Early Life Nutrition and the Microbiota-Gut-Brain Axis

Early-Life Nutrition and Gut Immune Development

Early life microbiome influences on development of the mucosal innate immune system

A Co-Culture Model of the Developing Small Intestine Offers New Insight in the Early Immunomodulation of Enterocytes and Macrophages by Lactobacillus spp. through STAT1 and NF-kB p65 Translocation

Lessons from mother: Long-term impact of antibodies in breast milk on the gut microbiota and intestinal immune system of breastfed offspring

Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease

The gut ecosystem and immune tolerance

The right educational environment: Oral tolerance in early life

Development of systemic and mucosal immune responses against gut microbiota in early life and implications for the onset of allergies

Infant Microbiota Communities and Human Milk Oligosaccharide Supplementation Independently and Synergistically Shape Metabolite Production and Immune Responses in Healthy Mice

Early life imprinting of intestinal immune tolerance and tissue homeostasis

Maternal‐driven immune education in offspring

Bifidobacteria-mediated immune system imprinting early in life

Mechanisms of microbe-mediated immune development in the context of antibiotics and asthma

High-resolution computational modeling of immune responses in the gut

Breastmilk IgG engages the neonatal immune system to instruct host-microbiota mutualism

Immune-microbe interactions early in life: A determinant of health and disease long term

Maternal gut microbiome–induced IgG regulates neonatal gut microbiome and immunity

Gut immunity and microbiome: from defense to metabolism (P3168)

Gut microbiota-reactive IgG regulates gut microbiota development and immunity against enteric pathogens in early life